JAZZ vs STEP · P/E 1988, rev $4.07B vs rev $1.99B
Jazz Pharmaceuticals PLC (JAZZ) versus Stepstone Group Inc (STEP) — a side-by-side from cached financials, not a winner call.
Jazz Pharmaceuticals PLC (JAZZ) is a biotechnology company listed on US.
Stepstone Group Inc (STEP) is a asset management company listed on NASDAQ.
Latest reported JAZZ revenue for 2024-12-31 was $4.07B. Net income was $560.1M. Revenue was up 6.1% from 2023-12-31 to 2024-12-31. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
Latest reported STEP revenue for 2026-03-31 was $1.99B. Net income was -$535.8M. Revenue was up 69.7% from 2025-03-31 to 2026-03-31. STEP currently screens at market cap $5.78B.
JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1. STEP currently screens at market cap $5.78B.
Not investment advice. Open the JAZZ and STEP stock pages for the full models.
Not investment advice.